RecruitingNCT05257954

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study


Sponsor

Josep Rodes-Cabau

Enrollment

500 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with frailty and transcatheter left atrial appendage closure. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IUCPQ_UL

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05257954


Related Trials